US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

Expert Analysis - Opinion

Gilead Ruling Signals That Innovating Can Lead To Liability

By Gary Myers · February 6, 2024, 5:15 PM EST

The Court of Appeal of the State of California ruled last month that a drug manufacturer can be liable for negligence for its delay in introducing an improved version of its...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Featured Stories

Courts Rule On DOJ Trans Care Subpoena, Abortion And More No Photo Available

Gianna Ferrarin

Law360 Healthcare Authority looks at a split Ninth Circuit decision backing the U.S. Department of Justice's administrative subpoena o... (more story)

Iowa Board Opens Door For Doctor Self-Defense Arguments No Photo Available

Mark Payne

An Iowa medical board's decision to dismiss disciplinary charges against a doctor who claimed the state's "stand your ground" law enab... (more story)

Lilly's Obesity Drug Suits Signal New Reality For GLP-1 Giants No Photo Available

Yeji Jesse Lee

Obesity-drug makers haven’t been shy about suing players encroaching on their turf. But a new round of lawsuits from Eli Lilly may sig... (more story)